LV10231A - Jaunas 3,3'-ditiobis(propionskabes) un to esteri to iegusanas panemiens farmaceitiskais preparats panemiens farmaceitiska preparata iegusanai - Google Patents

Jaunas 3,3'-ditiobis(propionskabes) un to esteri to iegusanas panemiens farmaceitiskais preparats panemiens farmaceitiska preparata iegusanai

Info

Publication number
LV10231A
LV10231A LV930822A LV930822A LV10231A LV 10231 A LV10231 A LV 10231A LV 930822 A LV930822 A LV 930822A LV 930822 A LV930822 A LV 930822A LV 10231 A LV10231 A LV 10231A
Authority
LV
Latvia
Prior art keywords
preparation
pharmaceutical preparation
dithiobis
esters
new
Prior art date
Application number
LV930822A
Other languages
English (en)
Other versions
LV10231B (en
Inventor
Carl-Magnus Alexand
Sten Hakan Axel Mag Bergstrand
Anders Rudolf Hallberg
Bengt Olof Saernstrand
Per Anders Sigvard Tunek
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9002275A external-priority patent/SE9002275D0/xx
Priority claimed from SE9002274A external-priority patent/SE9002274D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10231A publication Critical patent/LV10231A/lv
Publication of LV10231B publication Critical patent/LV10231B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Liquid Crystal Substances (AREA)
LVP-93-822A 1990-06-28 1993-06-30 Novel 3,3-dithiobis (propionic acids) and esters thereof LV10231B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002275A SE9002275D0 (sv) 1990-06-28 1990-06-28 Novel 3,3'-dithiobis(propionic acids)
SE9002274A SE9002274D0 (sv) 1990-06-28 1990-06-28 Novel 3,3'-dithiobis(propionic esters).

Publications (2)

Publication Number Publication Date
LV10231A true LV10231A (lv) 1994-10-20
LV10231B LV10231B (en) 1995-04-20

Family

ID=26660808

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-822A LV10231B (en) 1990-06-28 1993-06-30 Novel 3,3-dithiobis (propionic acids) and esters thereof

Country Status (31)

Country Link
EP (1) EP0463514B1 (lv)
JP (1) JPH04230359A (lv)
KR (1) KR920000714A (lv)
CN (1) CN1039318C (lv)
AT (1) ATE120730T1 (lv)
AU (1) AU642259B2 (lv)
CA (1) CA2045289A1 (lv)
CZ (1) CZ279343B6 (lv)
DE (1) DE69108616T2 (lv)
DK (1) DK0463514T3 (lv)
EG (1) EG20191A (lv)
ES (1) ES2070370T3 (lv)
FI (1) FI913131A (lv)
HK (1) HK62397A (lv)
HR (1) HRP920766A2 (lv)
HU (1) HU210675B (lv)
IE (1) IE71024B1 (lv)
IL (1) IL98389A (lv)
IS (1) IS1697B (lv)
JO (1) JO1677B1 (lv)
LV (1) LV10231B (lv)
NO (1) NO175307C (lv)
NZ (1) NZ238495A (lv)
PH (1) PH30951A (lv)
PL (2) PL165349B1 (lv)
PT (1) PT98121B (lv)
RU (1) RU2041208C1 (lv)
SI (1) SI9111086A (lv)
SK (1) SK278710B6 (lv)
TW (1) TW221376B (lv)
YU (1) YU48643B (lv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
SE9500897D0 (sv) * 1995-03-14 1995-03-14 Astra Ab The pharmacological use of certain cystine derivatives
CN101332157B (zh) * 1998-10-09 2012-01-11 味之素株式会社 半胱氨酸衍生物
SE9900438D0 (sv) * 1999-02-10 1999-02-10 Astra Ab The pharmacological use of certian cystine derivatives
US8295265B2 (en) 2005-11-16 2012-10-23 Htc Corporation Method for handling radio bearer messages during reset and reestablishment in a wireless system
US7829709B1 (en) 2007-08-10 2010-11-09 Marquette University Cysteine prodrugs to treat schizophrenia and drug addiction
EP2252596B1 (en) * 2008-02-07 2016-12-28 Marquette University Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
CN103319388B (zh) * 2013-06-08 2014-11-05 西安交通大学 一种双功能聚乙二醇衍生物及其制备方法
KR20160147960A (ko) 2014-04-25 2016-12-23 아지노모토 가부시키가이샤 면역자극제
JP2018536645A (ja) 2015-10-28 2018-12-13 味の素株式会社 免疫賦活剤
EP3395365A1 (en) 2017-04-28 2018-10-31 Ajinomoto Co., Inc. Immunostimulating agent
CN111072537B (zh) * 2019-12-20 2021-11-19 南京德尔诺医药科技有限公司 一种双乙酰化-l-胱氨酸的制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8205M (lv) * 1968-12-20 1970-09-14
US3878305A (en) * 1972-05-25 1975-04-15 Procter & Gamble Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids
US3952115A (en) * 1975-04-02 1976-04-20 The Procter & Gamble Company Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters
FR2503151A1 (fr) * 1981-04-02 1982-10-08 Morelle Jean Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
JPS62195356A (ja) * 1986-02-20 1987-08-28 Seiwa Kasei:Kk シスチン誘導体及びその塩

Also Published As

Publication number Publication date
HRP920766A2 (en) 1997-04-30
CN1057647A (zh) 1992-01-08
AU7828491A (en) 1992-01-02
SK278710B6 (sk) 1998-01-14
PL290857A1 (en) 1992-08-10
TW221376B (lv) 1994-03-01
HUT58048A (en) 1992-01-28
IE71024B1 (en) 1997-01-15
DE69108616T2 (de) 1995-10-19
CN1039318C (zh) 1998-07-29
IS1697B (is) 1998-08-28
FI913131A0 (fi) 1991-06-27
SI9111086A (en) 1997-12-31
RU2041208C1 (ru) 1995-08-09
CZ279343B6 (cs) 1995-04-12
NO912545L (no) 1991-12-30
KR920000714A (ko) 1992-01-29
ATE120730T1 (de) 1995-04-15
FI913131A (fi) 1991-12-29
YU48643B (sh) 1999-06-15
PT98121A (pt) 1992-03-31
IE912223A1 (en) 1992-01-01
LV10231B (en) 1995-04-20
PL165349B1 (pl) 1994-12-30
PL293118A1 (en) 1992-09-07
PL165344B1 (pl) 1994-12-30
EP0463514B1 (en) 1995-04-05
PT98121B (pt) 1998-12-31
CS199091A3 (en) 1992-04-15
EG20191A (en) 1997-09-30
YU108691A (sh) 1994-01-20
EP0463514A1 (en) 1992-01-02
DK0463514T3 (da) 1995-09-04
PH30951A (en) 1997-12-23
NO912545D0 (no) 1991-06-27
NZ238495A (en) 1995-06-27
NO175307B (no) 1994-06-20
IL98389A (en) 1997-04-15
ES2070370T3 (es) 1995-06-01
IL98389A0 (en) 1992-07-15
JO1677B1 (en) 1992-08-09
JPH04230359A (ja) 1992-08-19
AU642259B2 (en) 1993-10-14
HU210675B (en) 1995-06-28
HU912169D0 (en) 1991-12-30
CA2045289A1 (en) 1991-12-29
NO175307C (no) 1994-09-28
DE69108616D1 (de) 1995-05-11
IS3728A7 (is) 1991-12-29
HK62397A (en) 1997-05-16

Similar Documents

Publication Publication Date Title
HK37694A (en) Fatty acids compositions
LV10231A (lv) Jaunas 3,3'-ditiobis(propionskabes) un to esteri to iegusanas panemiens farmaceitiskais preparats panemiens farmaceitiska preparata iegusanai
HUT59600A (en) Process for producing pharmaceutical compositions containing 5-methyl-isoxazoe-4-carboxylik-anilides or alpha-/2-hydroxy-ethylidene/-alpha-cyano-acetic-anilides for treating eye-diseases
ES2070109T3 (es) Sales diaminicas de acido clavulanico.
EP0294667A3 (en) (2-cyano-2-oximinoacetyl)-amino acid derivatives
NO911892D0 (no) Fremgangsmaate for fremstilling og anvendelse som medikamenter av alfa-oksopyrrol(2,3-b)indoleddiksyrer, estere, amider og beslektede analoger.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
JPS5424845A (en) Novel bio-active peptide and its derivative
NO903994D0 (no) Fremgangsmaate for fremstilling av 5-aroyl-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer og alkylestere og salter derav.
EP0338494A3 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren
EP0338493A3 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren